These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 377743)

  • 21. [Continuous, low dosage estradiol administration with a vaginal ring: a placebo-controlled study].
    Casper F; Petri E; Benninghoff B
    Zentralbl Gynakol; 1998; 120(9):449-53. PubMed ID: 9796090
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Hormone treatment in menopause].
    Schindler AE
    MMW Munch Med Wochenschr; 1980 Jun; 122(26):967-9. PubMed ID: 6775194
    [No Abstract]   [Full Text] [Related]  

  • 23. [Estrogen metabolism and hormone substitution in the climacteric].
    Göretzlehner G; Kyank H
    Zentralbl Gynakol; 1985; 107(16):977-88. PubMed ID: 2996259
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Menstrual migraine: a double-blind trial of percutaneous estradiol.
    Dennerstein L; Morse C; Burrows G; Oats J; Brown J; Smith M
    Gynecol Endocrinol; 1988 Jun; 2(2):113-20. PubMed ID: 3055819
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of dysfunctional uterine bleeding in the perimenopause: the effects of adding combined estradiol/norethisterone acetate therapy to goserelin acetate treatment--a randomized, placebo-controlled, double-blind trial.
    Franke HR; Snaaijer FF; Houben PW; van der Mooren MJ
    Gynecol Endocrinol; 2006 Dec; 22(12):692-7. PubMed ID: 17162712
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Percutaneous estrogen therapy in the post-menopausal period].
    Keller PJ
    Schweiz Med Wochenschr; 1989 Jul; 119(29):999-1004. PubMed ID: 2678438
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Hormone replacement therapy in women with arterial hypertension in peri- and postmenopause: hemodynamic effects].
    Bystrova MM; Britov AN; Gorbunov VM; Lebedev AV; Eliseeva NA; Smetnik VP; Slasten OP
    Ter Arkh; 2001; 73(10):33-8. PubMed ID: 11763512
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical and endocrinologic studies of the treatment of ovarian insufficiency manifestations following hysterectomy with intact adnexa].
    Lehmann-Willenbrock E; Riedel HH
    Zentralbl Gynakol; 1988; 110(10):611-8. PubMed ID: 2841818
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A 1-year comparison of the efficacy and clinical tolerance in postmenopausal women of two hormone replacement therapies containing estradiol in combination with either norgestrel or trimegestone.
    Meuwissen JH; Beijers-De Bie L; Vihtamaki T; Tuimala R; Siseles N; Magaril C; The HS; Houben PW; Murga M; Spielmann D; De Villiers TJ
    Gynecol Endocrinol; 2001 Oct; 15(5):349-58. PubMed ID: 11727357
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The bioidentical hormone debate: are bioidentical hormones (estradiol, estriol, and progesterone) safer or more efficacious than commonly used synthetic versions in hormone replacement therapy?
    Holtorf K
    Postgrad Med; 2009 Jan; 121(1):73-85. PubMed ID: 19179815
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vaginal ring delivering estradiol and progesterone: a possible alternative to relieve climacteric symptoms.
    Ben-Chetrit A; Hochner-Celnikier D; Lindenberg T; Zacut D; Shimonovitz S; Gelber H; Spitz IM
    Isr Med Assoc J; 2005 May; 7(5):302-6. PubMed ID: 15909462
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endocrine and metabolic effects of low-dose estrogen-progestin treatment in climacteric women.
    Ylöstalo P; Kauppila A; Kivinen S; Tuimala R; Vihko R
    Obstet Gynecol; 1983 Dec; 62(6):682-6. PubMed ID: 6355937
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term safety of drospirenone-estradiol for hormone therapy: a randomized, double-blind, multicenter trial.
    Archer DF; Thorneycroft IH; Foegh M; Hanes V; Glant MD; Bitterman P; Kempson RL
    Menopause; 2005; 12(6):716-27. PubMed ID: 16278615
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A transdermal therapeutic system for hormonal therapy of climacteric deficiency pictures. A multicenter study].
    Kerzel C; Keller PJ
    Geburtshilfe Frauenheilkd; 1987 Aug; 47(8):565-8. PubMed ID: 3653671
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A new synthetic estrone derivative for the treatment of climacteric disorders].
    Cyran W
    Med Welt; 1979 Mar; 30(10):384-8. PubMed ID: 368495
    [No Abstract]   [Full Text] [Related]  

  • 36. Efficacy and safety of estriol replacement therapy for climacteric women.
    Yang TS; Tsan SH; Chang SP; Ng HT
    Zhonghua Yi Xue Za Zhi (Taipei); 1995 May; 55(5):386-91. PubMed ID: 7641124
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transvaginal estriol administration in postmenopausal women: a double blind comparative study of two different doses.
    Bottiglione F; Volpe A; Esposito G; Aloysio DD
    Maturitas; 1995 Nov; 22(3):227-32. PubMed ID: 8746880
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Results of a 5 years prospective study of estriol succinate treatment in patients with climacteric complaints.
    Lauritzen C
    Horm Metab Res; 1987 Nov; 19(11):579-84. PubMed ID: 3428874
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Study of the action of promestriene on hyperseborrhea of the scalp and the face].
    Huriez C; Brouet JF; Delaporte M; Thomas P
    Lille Med; 1977 Nov; 22(9 Suppl 2):736-8. PubMed ID: 147376
    [No Abstract]   [Full Text] [Related]  

  • 40. [Estrogen treatment of women in their climacteric].
    Fock D
    Katilolehti; 1978 Apr; 83(4):144-6. PubMed ID: 247035
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.